Raymundo Escutia Gutiérrez

Dr. Raymundo Escutia Gutiérrez

Farmacobiologia, Universidad de Guadalajara, CUCEI, Guadalajara, Jalisco, Mexico
orcid
Doctor of Public Health Sciences

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Angel Josabad Alonso-CastroAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
ARAlan Joel Ruiz-Padilla
Alan Joel Ruiz-Padilla
MOMiriam Ortiz-Cortes
Miriam Ortiz-Cortes
ECEleazar Carranza
Eleazar Carranza
MRMarco Antonio Ramírez-Morales
Marco Antonio Ramírez-Morales
JZJuan Ramon Zapata-Morales
Juan Ramon Zapata-Morales

29 August 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Angel Josabad Alonso-CastroAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
YRYeniley Ruiz-Noa
Yeniley Ruiz-Noa
GCGissela Cristel Martínez de la Cruz
Gissela Cristel Martínez de la Cruz
MRMarco Ramírez
Marco Ramírez
MDMartha Alicia Devezé-Álvarez
Martha Alicia Devezé-Álvarez
ARAlan Joel Ruiz-Padilla
Alan Joel Ruiz-Padilla
Background: Pediatric self-medication is based on the subjective interpretation of symptoms in children by the mother or an adult, the decision to self-medicate is made by a third party. The objective of this work is to provide information on the factors and practices associated with the self-medication of children among parents in Mexico. Methods: A cross-sectional and descriptive study was conducted between June 2020 and December 2021 on Mexican parents with children under 12 years of age. Online questionnaires were completed with sections on sociodemographic characteristics, use of medicines or medicinal plants and their treated symptoms, sources of collection, and their recommendation. Results: A total of 9905 online surveys were completed with representation from the 32 states of Mexico, and the prevalence of self-medication was 49.6% (n = 4908). Associated factors were age, having two or more children, children with chronic illnesses, medium educational level, unemployment or employment unrelated to health, medium and high socioeconomic level, and lack of medical security. Respondents self-medicated their children on the recommendation of a family member or friend (55.8%), and own initiative (28%). The most used medication was VapoRub (61.3%), followed by paracetamol (56.9%) and chamomile (33.1%), and the most prevalent symptoms were flu/flow (47.7%) followed by cough (34.2%). The main reasons were perceiving symptoms as not serious (69.9%) and reusing medications (51.9%). Conclusions: There is a high prevalence of self-medication in children in Mexico, mainly associated with children with chronic diseases and families with three or more children.

1 May 2015 in Clinical Biochemistry
Verified
Journal Article
Closed access
HLHilda Luna-Záizar
Hilda Luna-Záizar
MVMaría Virgen-Montelongo
María Virgen-Montelongo
CCCesar R. Cortez-Álvarez
Cesar R. Cortez-Álvarez
SRSandra L. Ruiz-Quezada
Sandra L. Ruiz-Quezada
Raymundo Escutia GutiérrezRaymundo Escutia Gutiérrez
Raymundo Escutia Gutiérrez
AMAdriana Patricia Mendizabal
Adriana Patricia Mendizabal

1 December 2007 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
Raymundo Escutia GutiérrezRaymundo Escutia Gutiérrez
Raymundo Escutia Gutiérrez
CÁCésar R. Cortéz Álvarez
César R. Cortéz Álvarez
RÁRosa M. Álvarez Álvarez
Rosa M. Álvarez Álvarez
JHJorge Lv Flores Hernández
Jorge Lv Flores Hernández
JGJéssica Gutiérrez Godínez
Jéssica Gutiérrez Godínez
JLJosé G. López Y López
José G. López Y López
Neither the purchase nor the distribution of pharmaceuticals in hospitals and community pharmacies in Mexico is under the care of pharmacists. Some are under control of physicians. This report presents the results of the implementation of somef pharmaceutical services for the Jalisco Pain Relief, and Palliative Care Institute (Palia Institute), under the direction of the Secretary of Health, Government of Jalisco. The services implemented were drug distribution system, Drug Information Service, Pharmacovigilance Program, and home pharmacotherapy follow-up pilot program for patients with advanced illness, with the ultimate using the appropriate medication. The drug distribution system included dispensing of opioid pain medications, antidepressants, anticonvulsants, NSAIDs, anxiolytic drugs, steroid drugs, laxatives, and anti-emetics. The frequently used drugs were morphine sulfate (62%), amitriptyline (6.4%), and dextropropoxyphene (5.8%). The Drug Information Service answered 114 consultations, mainly asked by a physician (71%) concerned with adverse drug reactions and contraindications (21%). The pharmacovigilance program identified 146 suspected adverse drug reactions and classified them reasonably as possible (27%), probable (69%), and certain (4%). These were attributed mainly to pregabalin and tramadol. The home pharmacotherapy follow-up pilot program cared patients with different cancer diagnoses and drug-related problems (DRP), which were identified and classified (according to second Granada Consensus) for pharmaceutical intervention as DRP 1 (5%), DRP 2 (10%), DRP 3 (14%), DRP 4 (19%), DRP 5 (24%), or DRP 6 (28%). This report provides information concerning the accurate use of medication and, above all, an opportunity for Mexican pharmacists to become an part of health teams seeking to resolve drug-related problems.

7 January 2026 in Pharmacy
Verified
Journal Article
Open access
PDF file
CRCarlos Estrada-De La Rosa
Carlos Estrada-De La Rosa
FAFelipe Avalos
Felipe Avalos
Daniel Osmar Suárez-RicoDaniel Osmar Suárez-Rico
Daniel Osmar Suárez-Rico
MZMartin Zermeño-Ruiz
Martin Zermeño-Ruiz
CCCesar Ricardo Cortez-Álvarez
Cesar Ricardo Cortez-Álvarez
Raymundo Escutia GutiérrezRaymundo Escutia Gutiérrez
Raymundo Escutia Gutiérrez
Background/Objectives: Benzodiazepines (BZDs) are used routinely in cases requiring sedation for anxiety, insomnia, and procedures that require pain management, and daily use of these agents may extend over several months; therefore, monitoring patients is essential to reduce the risk of developing dependence. However, the high patient volume in pain and palliative-care settings often limits physicians’ ability to both conduct consultations and perform comprehensive evaluations. In this context, the pharmacist plays a key role in supporting patient care by contributing professional activities that enhance patient well-being, such as conducting systematic reviews of electronic medical records. This pharmacist-led EMR assessment enables the identification of benzodiazepine dependence patterns and supports a more robust epidemiological evaluation within the institution. Methods: A descriptive observational study (January 2022–May 2025) using electronic medical records and prescription data was conducted. Consecutive adults with an active BZD prescription and a documented BDEPQ-MX (Benzodiazepine Dependence Questionnaire, Mexican version) were included. Outcomes were BDEPQ-MX categories (No dependence; Pleasurable effects; Perceived need; Dependence) and a binary endpoint was stablished as “any dependence” (either scored in Perceived need or Dependence category) vs. No dependence (either scored as No dependence or Pleasurable effects categories). Group comparisons used χ2, Student’s t, and one-way ANOVA. A logistic regression modeled any dependence; a general linear model (GLM) examined the BDEPQ-MX total score. Results: Of 181 complete cases, BDEPQ-MX categories were No dependence 33.2% (60/181), Pleasurable effects 7.2% (13/181), Perceived need 17.1% (31/181), and Dependence 42.5% (77/181); hence, 59.7% met “any dependence.” Women comprised 67.4% overall. Compared with No dependence, the any-dependence group had higher comorbidity (83.3% vs. 65.8%, p = 0.006) and markedly greater duration of BZD use (months) (22.6 ± 11.5 vs. 5.9 ± 4.9, p < 0.001), with no difference in daily dose (p = 0.6). Benzodiazepine medications shifted toward alprazolam in dependence (38.9% vs. 20.5%, p = 0.009) and away from clonazepam (43.5% vs. 58.9%, p = 0.042). In the adjusted model, the male sex was associated with lower odds of any dependence (aOR 0.29, 95% CI 0.11–0.76; p = 0.013), while the duration of BZD use (per month) increased the odds (aOR 1.32, 1.20–1.45; p < 0.001). In the GLM, the duration showed the largest effect on BDEPQ-MX total (F = 203.26; p < 0.001; partial η2 = 0.545). Conclusions: In this outpatient pain and palliative-care population, benzodiazepine-related dependence phenomena were common: 59.7% of patients met the criteria for dependence based on the pharmacist-led EMR review. The involvement of the pharmacist was essential, as this systematic evaluation would have been difficult to perform within routine medical consultations. The pharmacist’s contribution enabled a detailed epidemiological characterization, revealing that the exposure duration—more than daily dose—was the principal, modifiable correlate of dependence, and that alprazolam was disproportionately represented in the higher-dependence categories. These findings underscore the value of pharmacist-supported surveillance to identify and measure BZD dependance.

31 March 2026 in Epidemiologia
Verified
Journal Article
Open access
PDF file
Raymundo Escutia GutiérrezRaymundo Escutia Gutiérrez
Raymundo Escutia Gutiérrez
IHIgor Martin Ramos Herrera
Igor Martin Ramos Herrera
ADAnahi Dreser
Anahi Dreser
NCNelson Bruno de Almeida Cunha
Nelson Bruno de Almeida Cunha
Background and Objectives: The improper disposal of expired and unused medications (EUM) poses significant environmental and health risks. Discarding EUM in household trash or drains leads to accidental poisoning, illegal trade, and ecosystem contamination. These persistent compounds often resist wastewater treatment, disrupting ecological balance and contributing to antimicrobial resistance, thereby increasing morbidity and mortality rates. This study aims to analyze the knowledge, attitudes and practices (KAP) and related factors of the Mexican population regarding the disposal of EUM. Methods: A cross-sectional, descriptive, and correlational study was conducted via an online survey of adults (18+) from October 2021 to October 2024. Results: Among 6080 participants (95.4% aged 18–59; 65.8% women), a medium level of KAP was observed. Notably, 51.5% did not use specialized disposal containers, only 15.5% knew container locations, and 30.5% correctly identified expiration dates. Significant associations emerged: lower education levels correlated with poorer disposal knowledge, while health-related backgrounds and postgraduate studies linked to positive attitudes and adequate practices. Ordinal logistic regression revealed that being elderly, belonging to a high socioeconomic class, having lower education levels, and lacking health-related studies were significantly associated with poor KAP regarding EUM disposal. Conclusions: Inadequate pharmaceutical disposal in Mexico compromises environmental and public health. Addressing this requires reinforced regulations, professionalized pharmacies, and a comprehensive approach to bridge knowledge gaps. Integrating digital tools—like real-time mapping and QR labeling—with accessible take-back schemes is vital in mitigating hazards and uphold the One Health triad.